CGEM
CGEM
NASDAQ · Biotechnology

Cullinan Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$17.63
+0.33 (+1.91%)
As of Jun 23, 2:41 PM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +21.7% upside
Low Target $16.94
Average Target $21.45
High Target $32.37
Current Price $17.63
Current
$17.63
Target
$21.45
$16.94 $21.45 avg $32.37
Scenario Analysis
Bear Case
$16.94
-3.9%
Low target
Base Case
$21.45
+21.7%
Avg target
Bull Case
$32.37
+83.6%
High target
Risk/Reward
21.4x
Highly favorable
Price in Context
52-Week High
$16.74
5.3% from high
52-Week Low
$5.68
+210.4% from low
Target vs 52W High
$21.45
+28.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%